Heinz Lubenau

Company: Vaximm GmbH

Seminars:

Optimizing Patient Selection & Stratification to Improve Success in Clinical Trials 12:00 pm

What should the patient cohort selection look like to give best chance of success? Which clinical end points to be selected to assess anti-tumor efficacy? How can the late stage product manufacturing process look like for neoantigen programs?Read more

day: Day Two